GS vs NRXS · P/E 20, rev $58.28B vs rev $3.6M
Goldman Sachs Group Inc (GS) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David M. Solomon.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported GS revenue for 2025-12-31 was $58.28B. Net income was $17.18B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the GS and NRXS stock pages for the full models.
Not investment advice.